Technical Study: VIVUS Inc., Sanofi, DENTSPLY Intl. Inc., and Acura
Editor Note: For more information about this release, please scroll to bottom.
LONDON, September 17, 2013
LONDON, September 17, 2013 /PRNewswire/ --
The U.S. equity market finished on a mixed note on Monday, September 16, 2013.
The S&P 500 and the Dow Jones posted gains, while the NASDAQ Composite ended
slightly lower. Shares in the healthcare sector ended mostly higher, even as
the broader market finished on a mixed note. The major movers in the sector
included VIVUS Inc. (NASDAQ: VVUS), Sanofi (NYSE: SNY), DENTSPLY International
Inc. (NASDAQ: XRAY), and Acura Pharmaceuticals Inc. (NASDAQ: ACUR).
AAAResearchReports.com free coverage on VVUS, SNY, XRAY, and ACUR is available
upon registration at:
Shares in VIVUS Inc. rose sharply on Monday, even as the broader market
finished on a mixed note. The company's shares closed the day at $10.33, up
2.08% from the previous day's price of $10.12. A total of 1.64 million shares
were traded, which is below the daily average volume of 2.55 million. Despite
Monday's sharp gains, the company's shares have lost 0.77% in the previous
three trading sessions, underperforming the S&P 500 which has gained 0.50%
during the same period. Further, VIVUS Inc.'s stock is trading below its
50-day and 200-day moving averages of $13.05 and $12.17, respectively.
Download free technical research on VVUS by signing up at:
Sanofi's stock fluctuated between gains and losses before finishing the day
nearly flat on Monday. The company's shares closed the day at $47.95, down
0.02%, after oscillating between $47.95 and $48.48. A total of 2.39 million
shares were traded, which is below the daily average volume of 1.81 million.
Sanofi's shares have lost 2.56% in the last three trading sessions,
underperforming the S&P 500 which has gained 0.50% during the same period.
Furthermore, the company's stock is currently trading below its 50-day and
200-day moving averages of $51.02 and $50.47, respectively. Register now and
get access to free analysis on SNY at:
Shares in DENTSPLY International Inc. moved higher on Monday, even as the U.S.
equity market ended on a mixed note. The company's shares fluctuated between
$44.47 and $45.06 before closing the day 0.97% higher at $44.54. A total of
0.84 million shares were traded, which is more than the daily average volume
of 0.75 million. The company's shares have surged 8.61% in the previous three
months and 6.10% in the last one month, outperforming the S&P 500 which has
gained 4.36% and 2.52% during the respective periods. Further, DENTSPLY
International Inc.'s stock has moved closer to its 52-week high of $45.37 and
is currently trading above its 50-day and 200-day moving averages of $42.47
and $41.67, respectively. Sign up and read our complimentary report on XRAY
Acura Pharmaceuticals Inc.'s shares fluctuated between gains and losses before
finishing flat on Monday. The company's shares closed the day at the previous
day's closing price of $1.49 after oscillating between $1.46 and $1.53 during
the trading session. A total of 0.09 million shares were traded, which is
below the daily average volume of 0.39 million. Acura Pharmaceuticals Inc.'s
shares have lost 0.67% in the last three trading sessions, underperforming the
S&P 500 which has gained 0.50% during the same period. Additionally, the
company's stock is currently trading below its 50-day and 200-day moving
averages of $1.78 and $2.12, respectively. The free report on ACUR can be
downloaded by signing up now at:
1.This is not company news. We are an independent source and our views do
not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are
only human and are prone to make mistakes. If you notice any errors or
omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
increase awareness for mentioned companies to our subscriber base and the
4.If you wish to have your company covered in more detail by our team, or
wish to learn more about our services, please contact us at
5.For any urgent concerns or inquiries, please contact us at
6.Are you a public company? Would you like to see similar coverage on your
company? Send us a full investors' package to
research@EquityNewsNetwork.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Ananya Ghosh, CFA, has
only reviewed the information provided by Equity News Network in this article
or report according to the Procedures outlined by Equity News Network. Equity
News Network is not entitled to veto or interfere in the application of such
procedures by the outsourced provider to the articles, documents or reports,
as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
SOURCE AAA Research Reports
Contact: +1(646)396-9126, Peter F. Jones, email@example.com
Press spacebar to pause and continue. Press esc to stop.